Peyronie's Disease Treatment Protocol

NCT02072018 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Peyronie's Disease

Interventions

DRUG: H-100
DRUG: Placebo

Sponsor

Hybrid Medical